抗Wnt-5a抗体(Anti-Wnt-5a, Rat-Mono antibody)

掲載日情報:2018/11/26 現在Webページ番号:196399

Wnt-5aに対する抗体(Anti-Wnt-5a, Rat-Mono )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2024年04月28日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-Wnt-5a, Rat-Mono(442625)
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 14
説明文
別名:hWNT5A
クローン:442625
Genbank No: 7474
Protein Accession No: P22725
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Rat クラス IgG 標識 Unlabeled
交差性 Human 適用 IHC
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 R&D Systems 社 Wnt-5a関連製品
Wnt関連製品
関連記事
Anti-Human/Mouse Wnt-5a MAb (Clone 442625)
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 2
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:hWNT5A
クローン:442625
Genbank No: 7474
Protein Accession No: P22725
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Rat クラス IgG 標識 Unlabeled
交差性 Human 適用 IHC
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 Wnt関連製品
関連記事

[在庫・価格 :2024年04月28日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-Wnt-5a, Rat-Mono(442625)

文献数: 14

説明文 別名:hWNT5A
クローン:442625
Genbank No: 7474
Protein Accession No: P22725
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Rat
交差性 Human 適用 IHC
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 R&D Systems 社 Wnt-5a関連製品
Wnt関連製品
関連記事

Anti-Human/Mouse Wnt-5a MAb (Clone 442625)

文献数: 2

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:hWNT5A
クローン:442625
Genbank No: 7474
Protein Accession No: P22725
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Rat
交差性 Human 適用 IHC
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 Wnt関連製品
関連記事



目次に戻る

Product Details

Species ReactivityHuman, Mouse
LabelUnconjugated
ImmunogenCHO-derived recombinant mouse Wnt-5aGln38-Lys380Accession # P22725
SourceMonoclonal Rat IgG2A Clone # 442625
PurificationProtein A or G purified from hybridoma culture supernatant
SpecificityDetects mouse Wnt-5a in direct ELISAs and human and mouse Wnt‑5a in Western blots. In direct ELISAs, no cross-reactivity with recombinant mouse Wnt-1, 2b, 3a, 4, 5b, 8a, 8b, 9b, 10a, 10b, 11, or 16 is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Immunohistochemistry8-25 µg/mLSee below


Immunohistochemistry
Wnt‑5a in Mouse Embryo.
Wnt‑5a was detected in immersion fixed frozen sections of mouse embryo using Human/Mouse Wnt‑5a Monoclonal Antibody (Catalog # MAB645) at 10 µg/mL overnight at 4 °C. Tissue was stained using the NorthernLights™ 557-conjugated Anti‑Rat IgG Secondary Antibody (orange; Catalog # NL013) and counter­stained with DAPI (blue). View our protocol for Fluorescent IHC Staining of Frozen Tissue Sections.


目次に戻る

Related Product & Information

BackgroundWnt-5a
background_contentBackground:
Wnt-5a
Wnt proteins are secreted glycoproteins that contain a conserved pattern of 23‑24 cysteine residues. Wnts play critical roles in both carcinogenesis and embryonic development for a variety of organisms. Wnts bind to receptors of the Frizzled family, sometimes in conjunction with other membrane-associated proteins such as LRPs or proteoglycans. Downstream effects of Wnt signaling occur through different intracellular components, depending on which pathway is activated. Three pathways have been characterized: the canonical Wnt/ beta -catenin pathway, the Wnt/Ca2+ pathway, and the planar cell polarity (1‑2). Wnt-5a is part of the subgroup of Wnts that are not axis-inducing in Xenopus embryos and do not transform C57MG mammary epithelial cells. This subgroup is also implicated in the Wnt/Ca2+ pathway, playing roles in cell movements and cell adhesion (3). This non-canonical Wnt pathway can inhibit canonical Wnt/ beta -catenin signaling. In Wnt-5a deficient mouse embryos, beta -catenin accumulates in the limb bud suggesting that Wnt-5a normally promotes degradation of beta -catenin (4). Likewise, in Xenopus embryos Wnt-5a antagonizes the ability of the canonical Wnt subgroup to induce a secondary axis (5). Wnt-5a is implicated in various types of cancer and has complex roles. It acts as a tumor suppressor for mammary, B-cell, colon, and uroepithelial cancer cells but is up-regulated in melanomas, where expression levels correlate with severity of metastasis (3). Furthermore, aberrant Wnt-5a signaling results in other diseases such as rheumatoid arthritis (6). Like other developmental growth factors Wnt-5a has diverse roles in development. They are too numerous to enunciate here, as functions span from early anterior-posterior development and gastrulation movements to maintaining hematopoietic stem cell population, lung morphogenesis, and limb outgrowth. Mature Wnt-5a is a 49 kDa protein that shares 99% amino acid identity in mouse, rat and human.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling
    Authors: M Vesel, J Rapp, D Feller, E Kiss, L Jaromi, M Meggyes, G Miskei, B Duga, G Smuk, T Laszlo, I Karner, JE Pongracz
    Respir. Res, 2017;18(1):52.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC - Frozen

  2. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells
    Authors: TC Huang, PT Lee, MH Wu, CC Huang, CY Ko, YC Lee, DY Lin, YW Cheng, KH Lee
    PLoS ONE, 2017;12(8):e0181034.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Paraffin-embedded

  3. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition
    J Exp Clin Cancer Res, 2016;35(1):144.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  4. Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD
    Authors: Hoeke A Baarsma
    J. Exp. Med, 2016;0(0):.
    Species: Human
    Sample Type: Tissue Homogenates
    Application: WB

  5. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion.
    Authors: Fuster J, Zuriaga M, Ngo D, Farb M, Aprahamian T, Yamaguchi T, Gokce N, Walsh K
    Diabetes, 2015;64(4):1235-48.
    Species: Mouse
    Sample Type: Cell Lysates
    Application: WB

  6. Oncogenic effects of WNT5A in Epstein-Barr virusassociated nasopharyngeal carcinoma.
    Authors: Yap L, Ahmad M, Zabidi M, Chu T, Chai S, Lee H, Lim P, Wei W, Dawson C, Teo S, Khoo A
    Int J Oncol, 2014;44(5):1774-80.
    Species: Human
    Sample Type: Protein
    Application: WB

  7. Interleukin-6 drives melanoma cell motility through p38alpha-MAPK-dependent up-regulation of WNT5A expression.
    Authors: Linnskog R, Jonsson G, Axelsson L, Prasad C, Andersson T
    Mol Oncol, 2014;8(8):1365-78.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  8. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
    Authors: MacMillan, Connor D, Leong, Hon S, Dales, David W, Robertson, Amy E, Lewis, John D, Chambers, Ann F, Tuck, Alan B
    Sci Rep, 2014;4(0):6315.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  9. Wnt5a/beta-catenin signaling drives calcium-induced differentiation of human primary keratinocytes.
    Authors: Popp T, Steinritz D, Breit A, Deppe J, Egea V, Schmidt A, Gudermann T, Weber C, Ries C
    J Invest Dermatol, 2014;134(8):2183-91.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  10. Wnt5a promotes inflammatory responses via nuclear factor kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells.
    Authors: Zhao Y, Wang C, Li R, Hui T, Su Y, Yuan Q, Zhou X, Ye L
    J Biol Chem, 2014;289(30):21028-39.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。